New Tech Tonics Podcast – Carolyn Magill – May the Fast, Steep Road Rise Up to Meet You!

Digital Health

Biotech and Genetics David Shaywitz Digital Health Entrepreneurship Healthcare Information Technology Innovation Pharma/Biotech Uncategorized Aetion Carolyn Magill connected social media david shaywitz evolent Lisa Suennen tech tonics podcastCarolyn Magill had planned a life in foreign service or international relations. But it wasn’t until she found herself at the nexus of healthcare and public policy that she realized she found her home.

Benchling gets $14.5M to build collaboration tools for biotechs, pharmas

Mobi Health News

Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional participation by F-Prime Capital and returning investor Thrive Capital

China’s Burning Rock Biotech completes Series C financing of RMB 850 million

Mobi Health News

Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million.

New Tech Tonics Episode: Susan Desmond-Hellmann: The Inquisitive Leader

Digital Health

Her illustrious career has taken her from clinician to biotech executive to university chancellor to CEO of the world’s largest foundation, yet throughout this exceptional journey, Susan Desmond-Hellmann has remained empathetic, inquisitive, and emphatically true to herself.

I Want a New Drug, Part 2 –Digital Therapeutics on the Rise

Digital Health

In the last month I have spoken at an event about digital therapeutics and been invited to speak at 5 more unrelated events on the same topic (note: I am not doing them all).

New Tech Tonics Podcast: From Maine to Mainstream: The Noah Craft Story

Digital Health

Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Pharma/Biotech Tech Tonics Podcast connnected social media david shaywitz Lisa Suennen noah craft Sceince37 Science 37 siteless clinical trial Tech Tonics tech tonics podcst virtual clinical trial

Moderna, one of the biggest gambles in Biotech history to be tested on Wall Street with $10Bn IPO

Lloyd Price

One of the biggest gambles in biotech history is about to be tested on Wall Street. In its prospectus, Moderna set an initial target of $500 million for the offering, which would make it the largest biotech IPO in history.

New Tech Tonics Episode: Katherine Chou: How A Quintessential Googler Wraps Her (Deep) Mind Around Healthcare

Digital Health

Biotech and Genetics David Shaywitz Diagnostics and Screening Digital Health Healthcare Information Technology Innovation Tech Tonics Podcast Uncategorized connected social media david shaywitz dnanexus Google Deep Mind Google Medical Brain Katherine Chou Lisa SuennenKatherine Chou is in many ways the quintessential Googler – super smart, a passion for computer science, an engineer through and through.

New Tech Tonics Podcast: Lisa Alderson and her Long and Winding Road to Genomics

Digital Health

Biotech and Genetics Diagnostics and Screening Digital Health Entrepreneurship Healthcare Information Technology Innovation Precision Medicine Tech Tonics Podcast Uncategorized connected social media david shaywitz GE Ventures genetic testing Genome Medical Genomic Health Invitae Lisa Alderson Lisa Suennen Randy Scott Tech Tonics telemedicine for genetic counseling

$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018

Lloyd Price

For many biotech companies, mergers and acquisitions have become a cornerstone in building a robust pipeline that can ensure positive growth for years to come. 2017 was considered to be a lean year for M&A in biotech.

Americans’ Trust in the Healthcare System Low Compared to Rest-of-World’s Health Citizens

Health Populi

Biotech is roughly tied for second place with consumer health, dropping also by 7 points. In that context, look at chart #4, “Biotech Seen as the Laboratory vs Pharma.” In the U.S.,

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

There’s little Americans, by political party, agree upon in 2019. One of the only issues bringing people together in the U.S.

Consumers Consider Cost When They Think About Medical Innovation

Health Populi

Health Populi’s Hot Points: Americans draw a very big distinction between biotech and pharma when it comes to trust, this year’s Edelman Trust Barometer found.

Personalized Medicine: Consumer Concerns About Coverage, Affordability and Privacy

Health Populi

Two in 3 Americans haven’t heard the phrases “personalized medicine” or “precision medicine.”

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

This is what happened to pharma stock prices on Friday after President Trump and Secretary of Health and Human Services Alex Azar outlined their new policies focusing on prescription drug prices. The graph is the Nasdaq U.S.

LA BioMed closes $50M bond sale to finance biotech research lab


LA BioMed, a nonprofit scientific research organization on the Harbor-UCLA Medical Center Campus, attracted more than twice the offering size of its first bond issue. Here's what they plan to do with it

Why more physicians should enter industry


Attend any biotech or health informatics conference and one thing becomes clear: the scarcity of physicians.

Israeli government dips into digital health with $33M grant

Mobi Health News

Today the Israeli government announced a $33 million grant aimed at furthering the country's foothold in digital health, specifically in biotech and medicine, according to Reuters Israel is continuing to carve out its space as a digital health hub in the Middle East.

Northwestern inks $65M investment partnership to support research


The fund will be geared toward health and biotech discoveries at the Illinois university, officials said this week

Medidata acquires Shyft for $195M, establishes unified trial, commercialization data platform

Mobi Health News

Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced today that it has acquired Shyft Analytics, maker of a cloud data analytics platform specifically designed for the pharma and biotech industries

What the Pew Data on Americans’ Views on Technology Means for Healthcare

Health Populi

What was intriguing about that research is that biotech was much more trusted than pharma, with biotech being seen as more innovative. Through a marketing lens, then, the biotech has done a better job at bolstering consumer trust than pharma has done.

The Evolution of Self-Care for Consumers – Learning and Sharing at CHPA

Health Populi

Edelman’s health industry segments for this study are pharma, consumer health, insurance, biotech/life science, and hospitals. Consumer health went opposite, up 7 points, biotech up 3, insurance up 8, pharma up 6. Self-care in health goes back thousands of years.

Caretech as the new Digital Health

33 Charts

There’s precedent here with “fintech,” “biotech,” and “insuretech.” When it comes to health and technology, language matters. Chrissy Farr of CNBC during WWDC: ” Quick note that it’s 2 hours in and Apple has not used the term “digital health.” Perhaps only an internal thing? ”.

GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics

Lloyd Price

He believes that genetics predict Zejula will prove more effective in a larger percentage of cancer patients than biotech observers expect. It will also give Glaxo an oncology sales force and a toehold in Boston, which is a biotech hothouse.

Venture Capitalists have poured more than $26 Billion into Health Startups in 2018

Lloyd Price

And in biotech, genetic engineering startup Synthego also raised $110 million for its Series C from investors Menlo Ventures and billionaire Yahoo co-founder Jerry Yang.

Asia HealthTech Investment 2018 Report

Lloyd Price

HealthTech does not include Biotech, such as protein research or pharmaceuticals, and also does not include MedDev, such as devices that are implanted into the body.

Shelly Palmer De-Hypes CES 2019 & Has Lessons for Health/Care

Health Populi

As my friends at #JPM this week are hearing in San Francisco, AI is part of virtually every biotech and med-tech story. I had the pleasure once again of attending Shelly Palmer’s annual kick-off breakfast where he level-sets our expectations for CES two hours before the tech halls open.

What does the 2018 Connected Health Conference tell us about the state of the industry?

The cHealth Blog

This was the place for entrepreneurial healthcare providers, market-leading tech and medical device companies, pharma and biotech leaders, startups driving healthcare consumerization and organizations fueling the innovation economy to meet, network and create opportunities.

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. In 2018, spending on branded prescription drugs will fall in wealthy countries, while spending on specialty drugs will increase, resulting in flat medicines spending.

Obesity, Bariatric Surgery Devices Market Worldwide Top Key Players Revenue and Demand Forecasts to 2023

Healthcare Guys

and Cousin Biotech The obesity surgery devices market size is projected to reach $2.8 billion by 2023, growing at a CAGR of 9.9% during 2017-2023.

The Hypoglycemia Brain Trust

Insulin Nation

A ccording to a Fierce Biotech Research article, researchers have discovered an area of the brain that is in charge of communicating with the rest of the body about hypoglycemia. Quick Hit.

One Test, Every Disease

Import Immunity

Geekwire) Microsoft partners with Adaptive Biotech on AI-driven blood test to diagnose dozens of diseases at once The old blog still looks pretty ok after two years of inactivity!

Streamlining Healthcare Innovation: Working Together to Improve Digital Health Regulations

Mobile Health Matters

For example, at one time San Antonio and Austin, Texas had more than 200 biotech startups. This is a watershed moment in healthcare. New technologies are constantly in development to help treat and prevent previously incurable conditions, and improve current processes.

Medtronic acquires Israeli nutrition data startup Nutrino Health

Lloyd Price

Financing the Future of Digital Medicine Digital healthcare investments are benefiting from the surfeit of cash that is lifting the biotech sector and, in fact, all industries in 2018.

Uncovering the Hypoglycemia On/Off Switch

Insulin Nation

According to a press release published in Fierce Biotech Research , researchers from the University of Michigan and several UK and U.S. Quick Hits. Hypoglycemia is bad, and hypoglycemia unawareness is worse.

Fourth Wave: Digital Health Newsletter — Oct 30, 2018 — No. 110

Story of Digital Health

Digital Medicine 2018 Report: Part 2 – Financing the Future focuses on the ways in which digital healthcare investments are benefiting from the surfeit of cash that is lifting the biotech sector. The Fourth Wave: Digital Health Newsletter — Oct 30, 2018 — No.

Clinical Trials Go Virtual for iPhone Users

Insulin Nation

Quick Hit. Apple is giving its 700-million iPhone users the chance to become participants in virtual clinical trials to advance medical research.

Immunology, meet the Internet

Import Immunity

Software in biotech is in the same place as the pipette, but even more so. Traditionally in biotech, this is a “cliff” — download huge data files and start writing code to process them.

Tresiba Tries Again for FDA Approval

Insulin Nation

According to a Fierce Biotech report on Tresiba, Novo’s resubmission of Tresiba could backfire for a couple of reasons, say analysts. Quick Hit.